Pfizer Limited (BOM:500680)

India flag India · Delayed Price · Currency is INR
5,695.40
+22.05 (0.39%)
At close: Jun 27, 2025
23.61%
Market Cap 264.99B
Revenue (ttm) 22.81B
Net Income (ttm) 7.68B
Shares Out n/a
EPS (ttm) 167.79
PE Ratio 34.52
Forward PE 37.68
Dividend 165.00 (2.95%)
Ex-Dividend Date Jul 9, 2025
Volume 2,235
Average Volume 2,247
Open 5,747.00
Previous Close 5,673.35
Day's Range 5,639.70 - 5,787.60
52-Week Range 3,742.90 - 6,452.85
Beta n/a
RSI 62.13
Earnings Date Aug 4, 2025

About Pfizer

Pfizer Limited engages in manufacturing, marketing, trading, and export of pharmaceutical products in India and internationally. It offers its products in various therapeutic areas, including neuro/CNS, hormones, cardiovascular, haemophilia, anti-infectives, gynecology, pain/analgesics, orthopedic, oncology, urology, anti-parasitic, gastro intestinal, vaccines, and respiratory, as well as vitamins, minerals, and nutrients. The company also offers internal medicine and anti-infectives services to hospitals and nursing homes. It serves healthcare... [Read more]

Industry Pharmaceutical Preparations
Founded 1950
Employees 1,721
Stock Exchange Bombay Stock Exchange
Ticker Symbol 500680
Full Company Profile

Financial Performance

In 2024, Pfizer's revenue was 22.81 billion, an increase of 4.02% compared to the previous year's 21.93 billion. Earnings were 7.68 billion, an increase of 39.23%.

Financial Statements

News

There is no news available yet.